1. Home
  2. ACLX vs NSIT Comparison

ACLX vs NSIT Comparison

Compare ACLX & NSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACLX
  • NSIT
  • Stock Information
  • Founded
  • ACLX 2015
  • NSIT 1988
  • Country
  • ACLX United States
  • NSIT United States
  • Employees
  • ACLX N/A
  • NSIT N/A
  • Industry
  • ACLX Biotechnology: Pharmaceutical Preparations
  • NSIT EDP Services
  • Sector
  • ACLX Health Care
  • NSIT Technology
  • Exchange
  • ACLX Nasdaq
  • NSIT Nasdaq
  • Market Cap
  • ACLX 3.5B
  • NSIT 4.3B
  • IPO Year
  • ACLX 2022
  • NSIT 1995
  • Fundamental
  • Price
  • ACLX $67.16
  • NSIT $143.97
  • Analyst Decision
  • ACLX Strong Buy
  • NSIT Buy
  • Analyst Count
  • ACLX 14
  • NSIT 4
  • Target Price
  • ACLX $111.42
  • NSIT $185.00
  • AVG Volume (30 Days)
  • ACLX 567.9K
  • NSIT 304.2K
  • Earning Date
  • ACLX 08-07-2025
  • NSIT 07-31-2025
  • Dividend Yield
  • ACLX N/A
  • NSIT N/A
  • EPS Growth
  • ACLX N/A
  • NSIT N/A
  • EPS
  • ACLX N/A
  • NSIT 5.12
  • Revenue
  • ACLX $76,809,000.00
  • NSIT $8,425,769,000.00
  • Revenue This Year
  • ACLX N/A
  • NSIT $3.19
  • Revenue Next Year
  • ACLX $112.68
  • NSIT $4.72
  • P/E Ratio
  • ACLX N/A
  • NSIT $28.11
  • Revenue Growth
  • ACLX N/A
  • NSIT N/A
  • 52 Week Low
  • ACLX $47.86
  • NSIT $126.10
  • 52 Week High
  • ACLX $107.37
  • NSIT $228.07
  • Technical
  • Relative Strength Index (RSI)
  • ACLX 57.86
  • NSIT 65.85
  • Support Level
  • ACLX $63.13
  • NSIT $134.20
  • Resistance Level
  • ACLX $67.83
  • NSIT $136.64
  • Average True Range (ATR)
  • ACLX 2.49
  • NSIT 3.56
  • MACD
  • ACLX 0.09
  • NSIT 1.26
  • Stochastic Oscillator
  • ACLX 80.46
  • NSIT 85.72

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

About NSIT Insight Enterprises Inc.

Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.

Share on Social Networks: